Xiangyu Medical Co.,Ltd (688626.SS)
CNY 35.61
(1.02%)
CNY 35.61
(1.02%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 227.14 Million CNY | 81.03% |
| 2022 | 125.47 Million CNY | -37.85% |
| 2021 | 201.89 Million CNY | 2.87% |
| 2020 | 196.26 Million CNY | 52.17% |
| 2019 | 128.97 Million CNY | 60.56% |
| 2018 | 80.32 Million CNY | 24.59% |
| 2017 | 64.47 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 16.77 Million CNY | -4.46% |
| 2024 Q1 | 39.07 Million CNY | -18.56% |
| 2024 Q2 | 17.56 Million CNY | -55.05% |
| 2023 Q3 | 71.54 Million CNY | 2.51% |
| 2023 FY | 227.14 Million CNY | 81.03% |
| 2023 Q4 | 47.98 Million CNY | -32.94% |
| 2023 Q2 | 69.8 Million CNY | 84.6% |
| 2023 Q1 | 37.81 Million CNY | 16.13% |
| 2022 Q3 | 52.9 Million CNY | 73.31% |
| 2022 Q2 | 30.52 Million CNY | 222.12% |
| 2022 Q1 | 9.47 Million CNY | -86.55% |
| 2022 FY | 125.47 Million CNY | -37.85% |
| 2022 Q4 | 32.55 Million CNY | -38.46% |
| 2021 Q4 | 70.46 Million CNY | 56.28% |
| 2021 Q1 | 34.14 Million CNY | -57.47% |
| 2021 FY | 201.89 Million CNY | 2.87% |
| 2021 Q3 | 45.08 Million CNY | -13.62% |
| 2021 Q2 | 52.19 Million CNY | 52.86% |
| 2020 Q1 | 20.79 Million CNY | -46.69% |
| 2020 Q4 | 80.28 Million CNY | 107.28% |
| 2020 Q3 | 38.73 Million CNY | -31.38% |
| 2020 Q2 | 56.44 Million CNY | 171.44% |
| 2020 FY | 196.26 Million CNY | 52.17% |
| 2019 FY | 128.97 Million CNY | 60.56% |
| 2019 Q4 | 39 Million CNY | 0.0% |
| 2018 FY | 80.32 Million CNY | 24.59% |
| 2017 FY | 64.47 Million CNY | 0.0% |